A new biomarker in liver tumor may help doctors predict how patients respond to immunotherapy.
A novel targeting strategy may make pave the way for effective cancer immunotherapy against previously ‘undruggable’ targets.
Just because a molecular target resides inside a cancer cell does not mean that it cannot be targeted by antibodies, says Qi Zeng, founder of A*STAR spin-off company Intra-ImmuSG.
Virus-targeting white blood cells in tumors offer intriguing insights into responsiveness to immunotherapy
Generating large numbers of universal immune cells could transform cancer immunotherapy
Alterations in gene
regulation make gastric cancer cells less visible to the immune system
organic compound found in red wine boosts the body’s ability to fight drug-resistant
atlas of immune cells shows unexpected complexity, but could ultimately offer
valuable clinical insights
Immune system B cells play a role in tackling liver cancer and provide a marker for patient prognosis
Targeted stimulation of an immune pathway may help the body to fight back against liver cancer
The interaction between good and malignant immune cells may promote blood cancer invasiveness and progression